BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kopp AF, Laniado M, Dammann F, Stern W, Grönewäller E, Balzer T, Schimpfky C, Claussen CD. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology. 1997;204:749-756. [PMID: 9280254 DOI: 10.1148/radiology.204.3.9280254] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Deloison B, Siauve N, Aimot S, Balvay D, Thiam R, Cuenod C, Ville Y, Clement O, Salomon L. SPIO-enhanced magnetic resonance imaging study of placental perfusion in a rat model of intrauterine growth restriction: Placental perfusion in MRI. BJOG: An International Journal of Obstetrics & Gynaecology 2012;119:626-33. [DOI: 10.1111/j.1471-0528.2011.03251.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
2 Perea H, Aigner J, Heverhagen JT, Hopfner U, Wintermantel E. Vascular tissue engineering with magnetic nanoparticles: seeing deeper. J Tissue Eng Regen Med 2007;1:318-21. [PMID: 18038423 DOI: 10.1002/term.32] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
3 Ros PR, Davis GL. The incidental focal liver lesion: Photon, proton, or needle? Hepatology 1998;27:1183-90. [DOI: 10.1002/hep.510270501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kato N, Takahashi M, Tsuji T, Ihara S, Brautigam M, Miyazawa T. Dose-Dependency and Rate of Decay of Efficacy of Resovist on MR Images in a Rat Cirrhotic Liver Model: . Investigative Radiology 1999;34:551. [DOI: 10.1097/00004424-199909000-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
5 Sato I, Umemura M, Mitsudo K, Kioi M, Nakashima H, Iwai T, Feng X, Oda K, Miyajima A, Makino A, Iwai M, Fujita T, Yokoyama U, Okumura S, Sato M, Eguchi H, Tohnai I, Ishikawa Y. Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells. J Physiol Sci 2014;64:177-83. [PMID: 24619404 DOI: 10.1007/s12576-014-0309-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
6 Takamatsu S, Matsui O, Gabata T, Kobayashi S, Okuda M, Ougi T, Ikehata Y, Nagano I, Nagae H. Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med. 2008;26:179-187. [PMID: 18509717 DOI: 10.1007/s11604-007-0212-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
7 Bárcena C, Sra AK, Gao J. Applications of Magnetic Nanoparticles in Biomedicine. In: Liu JP, Fullerton E, Gutfleisch O, Sellmyer D, editors. Nanoscale Magnetic Materials and Applications. Boston: Springer US; 2009. pp. 591-626. [DOI: 10.1007/978-0-387-85600-1_20] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Nishie A, Asayama Y, Ishigami K, Tajima T, Kakihara D, Nakayama T, Takayama Y, Okamoto D, Taketomi A, Shirabe K. MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging. 2012;36:664-671. [PMID: 22532503 DOI: 10.1002/jmri.23691] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
9 Zeisser-labou������������������be M, Vargas A, Delie F. Nanoparticles for Photodynamic Therapy of Cancer. In: Kumar CSSR, editor. Nanotechnologies for the Life Sciences. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2007. [DOI: 10.1002/9783527610419.ntls0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002;223:432-8. [PMID: 11997549 DOI: 10.1148/radiol.2232010241] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 4.9] [Reference Citation Analysis]
11 Bellin MF. MR contrast agents, the old and the new. Eur J Radiol. 2006;60:314-323. [PMID: 17005349 DOI: 10.1016/j.ejrad.2006.06.021] [Cited by in Crossref: 165] [Cited by in F6Publishing: 138] [Article Influence: 10.3] [Reference Citation Analysis]
12 Kirchin MA, Pirovano G, Venetianer C, Spinazzi A. Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging 2001;14:281-94. [PMID: 11536405 DOI: 10.1002/jmri.1184] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
13 Earls JP, Bluemke DA. NEW MR IMAGING CONTRAST AGENTS. Magnetic Resonance Imaging Clinics of North America 1999;7:255-73. [DOI: 10.1016/s1064-9689(21)00021-0] [Cited by in Crossref: 20] [Article Influence: 0.9] [Reference Citation Analysis]
14 Thomsen HS, Morcos SK. ESUR guidelines on contrast media. Abdom Imaging 2006;31:131-40. [DOI: 10.1007/s00261-005-0380-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
15 Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595-601. [DOI: 10.1002/jmri.1224] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ward J, Chen F, Guthrie JA, Wilson D, Lodge JP, Wyatt JI, Robinson PJ. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology. 2000;214:159-166. [PMID: 10644117 DOI: 10.1148/radiology.214.1.r00ja21159] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
17 Daldrup-Link HE. Ten Things You Might Not Know about Iron Oxide Nanoparticles. Radiology. 2017;284:616-629. [PMID: 28825888 DOI: 10.1148/radiol.2017162759] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 14.4] [Reference Citation Analysis]
18 Kojima H, Mukai Y, Yoshikawa M, Kamei K, Yoshikawa T, Morita M, Inubushi T, Yamamoto TA, Yoshioka Y, Okada N, Seino S, Nakagawa S. Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent. Bioconjug Chem 2010;21:1026-31. [PMID: 20446679 DOI: 10.1021/bc900487p] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
19 Lencioni R, Cioni D, Crocetti L, Pina CD, Bartolozzi C. Magnetic resonance imaging of liver tumors. Journal of Hepatology 2004;40:162-71. [DOI: 10.1016/s0168-8278(03)00455-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
20 Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, Heverhagen JT, Prosperi D, Parak WJ. Biological applications of magnetic nanoparticles. Chem Soc Rev 2012;41:4306-34. [PMID: 22481569 DOI: 10.1039/c2cs15337h] [Cited by in Crossref: 844] [Cited by in F6Publishing: 647] [Article Influence: 84.4] [Reference Citation Analysis]
21 Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012;112:5818-78. [PMID: 23043508 DOI: 10.1021/cr300068p] [Cited by in Crossref: 1330] [Cited by in F6Publishing: 1001] [Article Influence: 133.0] [Reference Citation Analysis]
22 Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging. 2009;29:328-335. [PMID: 19161184 DOI: 10.1002/jmri.21615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
23 Reimer P, Müller M, Marx C, Balzer T. Evaluation of the Time Window for Resovist-Enhanced T2-Weighted MRI of the Liver. Academic Radiology 2002;9:S336-8. [DOI: 10.1016/s1076-6332(03)80222-2] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
24 Lu CW, Hsiao JK, Liu HM, Wu CH. Characterization of an iron oxide nanoparticle labelling and MRI-based protocol for inducing human mesenchymal stem cells into neural-like cells. Sci Rep. 2017;7:3587. [PMID: 28620162 DOI: 10.1038/s41598-017-03863-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kim MJ, Kim JH, Choi JY, Park SH, Chung JJ, Kim KW, Mitchell DG. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-66. [PMID: 16928903 DOI: 10.2214/AJR.05.0706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Morana G, Grazioli L, Testoni M, Caccia P, Procacci C. Contrast Agents for Hepatic Magnetic Resonance Imaging: . Topics in Magnetic Resonance Imaging 2002;13:117-50. [DOI: 10.1097/00002142-200206000-00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
27 Butoescu N, Jordan O, Petri-fink A, Hofmann H, Doelker E. Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery. Journal of Microencapsulation 2008;25:339-50. [DOI: 10.1080/02652040801999551] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
28 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
29 Butoescu N, Seemayer CA, Palmer G, Guerne PA, Gabay C, Doelker E, Jordan O. Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther 2009;11:R72. [PMID: 19454011 DOI: 10.1186/ar2701] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
30 Stiskal M, Demsar F, M�hler A, Schwickert HC, Roberts TP, Szolar D, Fischer H, Brasch RC. Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: Functional assessment of experimental radiation-induced liver injury. J Magn Reson Imaging 1999;10:52-6. [DOI: 10.1002/(sici)1522-2586(199907)10:1<52::aid-jmri7>3.0.co;2-c] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
31 Tombach B, Reimer P, Bremer C, Allkemper T, Engelhardt M, Mahler M, Ebert W, Heindel W. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed 2004;17:500-6. [DOI: 10.1002/nbm.906] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
32 Sonoda A, Nitta N, Nitta-Seko A, Ohta S, Takamatsu S, Ikehata Y, Nagano I, Jo J, Tabata Y, Takahashi M, Matsui O, Murata K. Complex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potential. Int J Nanomedicine 2010;5:499-504. [PMID: 20957172 DOI: 10.2147/ijn.s10944] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-30. [DOI: 10.1007/s00330-007-0602-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
34 Hekimoglu K, Ustundag Y, Dusak A, Kalaycioglu B, Besir H, Engin H, Erdem O. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Eur J Radiol 2011;77:468-72. [PMID: 19781882 DOI: 10.1016/j.ejrad.2009.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
35 Wang AZ, Gu FX, Farokhzad OC. Nanoparticles for Cancer Diagnosis and Therapy. In: Webster TJ, editor. Safety of Nanoparticles. New York: Springer; 2009. pp. 209-35. [DOI: 10.1007/978-0-387-78608-7_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
36 Braga L, Guller U, Semelka RC. Modern hepatic imaging. Surg Clin North Am. 2004;84:375-400. [PMID: 15062651 DOI: 10.1016/s0039-6109(03)00227-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
37 Zaitsev VS, Filimonov DS, Presnyakov IA, Gambino RJ, Chu B. Physical and Chemical Properties of Magnetite and Magnetite-Polymer Nanoparticles and Their Colloidal Dispersions. Journal of Colloid and Interface Science 1999;212:49-57. [DOI: 10.1006/jcis.1998.5993] [Cited by in Crossref: 240] [Cited by in F6Publishing: 197] [Article Influence: 10.4] [Reference Citation Analysis]
38 Tsuchiya K, Nitta N, Sonoda A, Otani H, Takahashi M, Murata K, Shiomi M, Tabata Y, Nohara S. Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: New possibilities for mannan-coated particles. European Journal of Radiology 2013;82:1919-25. [DOI: 10.1016/j.ejrad.2013.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
39 Lindemann A, Lüdtke-Buzug K, Fräderich BM, Gräfe K, Pries R, Wollenberg B. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Int J Nanomedicine 2014;9:5025-40. [PMID: 25378928 DOI: 10.2147/IJN.S63873] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kato N, Ihara S, Tsujimoto T, Miyazawa T. Effect of Resovist on Rats With Different Severities of Liver Cirrhosis: . Investigative Radiology 2002;37:292-8. [DOI: 10.1097/00004424-200205000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
41 Clarke SE, Weinmann HJ, Dai E, Lucas AR, Rutt BK. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology 2000;214:787-94. [PMID: 10715047 DOI: 10.1148/radiology.214.3.r00mr25787] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
42 Onishi H, Murakami T, Kim T, Hori M, Hirohashi S, Matsuki M, Narumi Y, Imai Y, Sakurai K, Nakamura H. Safety of ferucarbotran in MR imaging of the liver: a pre- and postexamination questionnaire-based multicenter investigation. J Magn Reson Imaging 2009;29:106-11. [PMID: 19097079 DOI: 10.1002/jmri.21608] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
43 Chen F, Ward J, Robinson P. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents. Magnetic Resonance Imaging 1999;17:549-56. [DOI: 10.1016/s0730-725x(98)00193-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
44 Belete A, Metz H, Mueller T, Maeder K. Benchtop MRI for pharmacokinetic evaluation of two aqueous-based nano-scaled formulations of oleic acid stabilized magnetite nanocrystals. Drug Development and Industrial Pharmacy 2015;41:406-14. [DOI: 10.3109/03639045.2013.871552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Hori M, Murakami T, Kim T, Takahashi S, Oi H, Tomoda K, Narumi Y, Nakamura H. Sensitivity of double-phase helical CT during arterial portography for detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 1998;22:861-867. [PMID: 9843222 DOI: 10.1097/00004728-199811000-00004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
46 Bellin M, Webb JAW, Van Der Molen AJ, Thomsen HS, Morcos SK; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Safety of MR liver specific contrast media. Eur Radiol 2005;15:1607-14. [DOI: 10.1007/s00330-004-2612-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
47 Ichihashi S, Marugami N, Tanaka T, Iwakoshi S, Kurumatani N, Kitano S, Nogi A, Kichikawa K. Preliminary experience with superparamagnetic iron oxide-enhanced dynamic magnetic resonance imaging and comparison with contrast-enhanced computed tomography in endoleak detection after endovascular aneurysm repair. Journal of Vascular Surgery 2013;58:66-72. [DOI: 10.1016/j.jvs.2012.12.061] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
48 Tomita K, Tanimoto A, Irie R, Kikuchi M, Yokoyama H, Teratani T, Suzuki T, Taguchi T, Noguchi M, Ohkura T. Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2008;28:1444-1450. [PMID: 19025953 DOI: 10.1002/jmri.21596] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
49 Runge VM, Heverhagen JT. Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance. Invest Radiol 2018;53:381-9. [PMID: 29462023 DOI: 10.1097/RLI.0000000000000454] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 5.3] [Reference Citation Analysis]
50 Davies BE, Kirchin MA, Bensel K, Lorusso V, Davies A, Parker JR, Lafrance ND. Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function. Invest Radiol 2002;37:299-308. [PMID: 11979156 DOI: 10.1097/00004424-200205000-00008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
51 Lunov O, Syrovets T, Röcker C, Tron K, Nienhaus GU, Rasche V, Mailänder V, Landfester K, Simmet T. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 2010;31:9015-22. [PMID: 20739059 DOI: 10.1016/j.biomaterials.2010.08.003] [Cited by in Crossref: 134] [Cited by in F6Publishing: 123] [Article Influence: 11.2] [Reference Citation Analysis]
52 Tsuchiya K, Nitta N, Sonoda A, Nitta-Seko A, Ohta S, Takahashi M, Murata K, Mukaisho K, Shiomi M, Tabata Y, Nohara S. Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings. Int J Nanomedicine 2012;7:2271-80. [PMID: 22619561 DOI: 10.2147/IJN.S29417] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
53 Nuzhina JV, Shtil AA, Prilepskii AY, Vinogradov VV. Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines. Journal of Drug Delivery Science and Technology 2019;54:101282. [DOI: 10.1016/j.jddst.2019.101282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
54 Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imaging 2007;25:755-65. [PMID: 17335040 DOI: 10.1002/jmri.20873] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
55 Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ, Heider P. Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging 2011;27:901-12. [PMID: 20972832 DOI: 10.1007/s10554-010-9736-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
56 Freund B, Tromsdorf UI, Bruns OT, Heine M, Giemsa A, Bartelt A, Salmen SC, Raabe N, Heeren J, Ittrich H, Reimer R, Hohenberg H, Schumacher U, Weller H, Nielsen P. A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano 2012;6:7318-25. [PMID: 22793497 DOI: 10.1021/nn3024267] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.2] [Reference Citation Analysis]
57 Hahn PF, Saini S. Liver-specific MR imaging contrast agents. Radiol Clin North Am. 1998;36:287-297. [PMID: 9520982 DOI: 10.1016/s0033-8389(05)70022-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Pech M, Ricke J, Seidensticker M, Staskiewicz G, Wieners G, Mohnike K, Ruhl R, Steinberg J, Wust P, Seidensticker P. Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO. Int J Radiat Biol 2008;84:830-7. [PMID: 18979318 DOI: 10.1080/09553000802389660] [Reference Citation Analysis]
59 Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol 2011; 17(42): 4654-4659 [PMID: 22180707 DOI: 10.3748/wjg.v17.i42.4654] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]